Tailored solutions for every modality – from blood plasma to mRNA
ZETA is a trusted partner in designing and delivering cutting-edge facilities across the full spectrum of pharmaceutical and biotech modalities. Whether supporting established manufacturing platforms or enabling next-generation therapies, ZETA combines engineering precision, regulatory expertise, and scalable solutions to bring complex medicines safely and efficiently to market.
Comprehensive expertise across modalities
- Blood plasma processing: Advanced systems that safeguard product integrity, maximise protein recovery, and ensure regulatory compliance.
- Recombinant proteins and peptides: Flexible upstream and downstream platforms for scalable, high-yield production.
- Aseptic manufacturing for vaccines and parenterals: Proven aseptic solutions, cold chain management, and emulsion systems for global supply.
- Manufacturing monoclonal antibodies: End-to-end mAb facilities with seamless scale-up and robust downstream purification.
- Solutions for antibody-drug conjugate manufacturing (ADCs): High-containment systems for safe handling of potent APIs and GMP-compliant conjugation.
- Cell and gene therapies: Scalable and customizable solutions for patient-specific, next-generation therapeutics.
- mRNA vaccines & therapeutics: Agile, GMP-compliant systems for template preparation, IVT, purification, and LNP formulation.
- Compounding and fill & finish: Closed-system compounding and automated fill lines for sterility assurance and regulatory alignment.
- Oral solid dosage (OSD) facility design: End-to-end support for tablets and capsules, including high-potency containment and bioavailability optimisation.
- Radiopharmaceuticals: Facilities that integrate GMP with radiation safety standards for time-critical nuclear medicine production.
Partnering for success
From early design to commercial production, ZETA’s interdisciplinary teams deliver modular, flexible, and future-ready facilities. The company ensures:
- Full regulatory alignment (FDA, EMA, radiation safety).
- Seamless integration of automation and digital tools.
- Scalable systems supporting clinical to commercial supply.
- Optimisation of cost, yield, and sustainability.